It has also been demonstrated that the administration of TLR9 ligand CpG-ODN 15 min after cerebral ischemia significantly reduced cerebral I/R injury via a PI3K/Akt-dependent mechanism [80]. The gene discussed is TLR9; the disease is brain ischemia.